NCT02390882View on ClinicalTrials.gov

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

PHASE3CompletedINTERVENTIONAL
Enrollment

494

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2015

Conditions
Benign Prostate Hyperplasia
Interventions
DRUG

Placebo

Placebo

DRUG

HGP0412 capsule

Tamsulon high dose

DRUG

HIP1402 capsule

Tamsulon high dose

Trial Locations (1)

Unknown

Hanyang University Guri Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02390882 - A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH | Biotech Hunter | Biotech Hunter